KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Cost of Revenue (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Cost of Revenue for 17 consecutive years, with $348.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 6.89% to $348.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 4.68% increase, with the full-year FY2025 number at $1.2 billion, up 4.69% from a year prior.
  • Cost of Revenue was $348.0 million for Q4 2025 at Bio-Rad Laboratories, up from $309.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $348.0 million in Q4 2025 to a low of $279.4 million in Q1 2025.
  • A 5-year average of $309.7 million and a median of $309.6 million in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: rose 28.88% in 2021, then fell 11.06% in 2024.
  • Bio-Rad Laboratories' Cost of Revenue stood at $334.3 million in 2021, then fell by 0.35% to $333.2 million in 2022, then fell by 5.51% to $314.8 million in 2023, then grew by 3.42% to $325.6 million in 2024, then increased by 6.89% to $348.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Cost of Revenue are $348.0 million (Q4 2025), $309.6 million (Q3 2025), and $306.3 million (Q2 2025).